(2023). A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy, Including Boost.. ClinicalTrials.gov.
Chicago Zitierstil"A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors On PD1/PDL1 Inhibitor Therapy, Including Boost.." ClinicalTrials.gov 2023.
MLA Zitierstil"A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors On PD1/PDL1 Inhibitor Therapy, Including Boost.." ClinicalTrials.gov 2023.